logo-loader

Carclo shares jump after rejecting a 116p a share takeover approach from Consort Medical

Published: 11:05 02 Jul 2018 BST

Takeover approach
Consort noted that its non-binding, all-share acquisition proposal represents a premium of approximately 43.6% to Carclo's closing share price of 80.8p last Friday

Carclo PLC (LON:CAR) shares jumped higher in early trading on Monday after Consort Medical PLC (LON:CRST) revealed it made a 116p per share takeover approach at the end of May which the global technical plastics products supplier rejected.

In a statement, Consort - which makes drug delivery devices such as inhalers - said Carclo has also rejected subsequent requests from it for a meeting to discuss its proposal.

READ: Carclo dips as profits fall during “disappointing” year of trading

Consort noted that its non-binding, all-share acquisition proposal represents a premium of approximately 43.6% to Carclo's closing share price of 80.8p last Friday.

As of June 29, it added, the valuation implied an exchange ratio of 0.0973 Consort shares for each Carclo share.

The predator company said it believes that the proposal "offers shareholders in Carclo an attractive upfront premium along with meaningful participation in the value creation over time as benefits of combining Bespak and Carclo Technical Plastics are realised."

Carclo, as at 11.00am, had issued no response to Consort’s statement.

In late morning trading, Carclo shares were 18.8% higher at 91.6p, while Consort shares were unchanged at 1,192.00p each.

Chesnara reports strong 2023 results with improved cash generation and...

Chesnara PLC (LSE:CSN) chief executive Steve Murray discusses the company's full-year results for 2023 with Proactive's Stephen Gunnion, describing them as strong and particularly highlighting £53 million in commercial cash generation and a dividend coverage of around 150%. The company has...

19 minutes ago